Taiko Pharmaceutical Co (TSE:4574) Short-Term Debt : 円1,276 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Taiko Pharmaceutical Co Short-Term Debt?

Taiko Pharmaceutical Co's Short-Term Debt for the quarter that ended in Mar. 2024 was 円1,276 Mil.

Taiko Pharmaceutical Co's quarterly Short-Term Debt increased from Sep. 2023 (円1,109 Mil) to Dec. 2023 (円1,206 Mil) and increased from Dec. 2023 (円1,206 Mil) to Mar. 2024 (円1,276 Mil).

Taiko Pharmaceutical Co's annual Short-Term Debt increased from Mar. 2020 (円0 Mil) to Dec. 2021 (円923 Mil) and increased from Dec. 2021 (円923 Mil) to Dec. 2022 (円1,039 Mil).

Taiko Pharmaceutical Co Short-Term Debt Historical Data

The historical data trend for Taiko Pharmaceutical Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiko Pharmaceutical Co Short-Term Debt Chart

Taiko Pharmaceutical Co Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Dec21

Dec22

Short-Term Debt

Get a 7-Day Free Trial

923.00

1,039.00

Taiko Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															969.00	969.00	1,109.00	1,206.00	1,276.00

Taiko Pharmaceutical Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Taiko Pharmaceutical Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Taiko Pharmaceutical Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiko Pharmaceutical Co (TSE:4574) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taiko Pharmaceutical Co Ltd (TSE:4574) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 34 Third Street, No. 14, Uchihon Suita, Osaka, JPN, 564-0032

Website

http://www.seirogan.co.jp

Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.

Taiko Pharmaceutical Co (TSE:4574) Headlines

No Headlines